Advaite Revenue and Competitors
Estimated Revenue & Valuation
- Advaite's estimated annual revenue is currently $1.1M per year.
- Advaite's estimated revenue per employee is $155,000
Employee Data
- Advaite has 7 Employees.
- Advaite grew their employee count by 0% last year.
Advaite's People
Name | Title | Email/Phone |
---|---|---|
1 | Sr. Research Scientist | Reveal Email/Phone |
2 | Senior Research Scientist | Reveal Email/Phone |
3 | Research Scientist | Reveal Email/Phone |
Advaite Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.4M | 9 | -10% | N/A | N/A |
#2 | $7.1M | 46 | 77% | N/A | N/A |
#3 | $14.4M | 93 | 27% | N/A | N/A |
#4 | $0.9M | 6 | 0% | N/A | N/A |
#5 | $1.6M | 10 | 43% | N/A | N/A |
#6 | $11.5M | 74 | 6% | N/A | N/A |
#7 | $0.9M | 11 | 22% | N/A | N/A |
#8 | $3.7M | 24 | -8% | N/A | N/A |
#9 | $2M | 13 | 18% | N/A | N/A |
#10 | $9.3M | 60 | 2% | N/A | N/A |
What Is Advaite?
ADVAITE Inc. is a Malvern, PA headquartered biotech company focused on developing novel therapeutics and diagnostics to help patients suffering from a variety of debilitating diseases. The word ‘Advaite’ means ‘one without a second’, unrivaled or unique. At ADVAITE, we aspire to be just that. Currently, ADVAITE Inc. is focused on developing novel point-of-care assays to help combat the modern world’s deadliest disease, COVID-19. With a new high complexity CLIA laboratory based in Chicago, Illinois and an expanded state-of the-art R&D facility in Malvern, PA; ADVAITE is continuously innovating, developing and commercializing point-of-care tests to address this pandemic and help impact large populations.
keywords:N/AN/A
Total Funding
7
Number of Employees
$1.1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.1M | 7 | 17% | N/A |
#2 | $0.5M | 7 | -30% | N/A |
#3 | $1.1M | 7 | -65% | N/A |
#4 | $0.5M | 7 | -22% | N/A |
#5 | $0.5M | 7 | N/A | N/A |